173 related articles for article (PubMed ID: 33082889)
21. Residual pleural thickening is related to vascular endothelial growth factor levels in parapneumonic pleural effusions.
Papaioannou AI; Kostikas K; Tsopa P; Kiropoulos T; Tsilioni I; Oikonomidi S; Gerogianni I; Gourgoulianis KI
Respiration; 2010; 80(6):472-9. PubMed ID: 20029166
[TBL] [Abstract][Full Text] [Related]
22. [Diagnostic value of pleural fluid and serum procalcitonin levels in the diagnosis of parapneumonic pleural effusion].
Doğan C; Bilaçeroğlu S; Çirak AK; Özsöz A; Özbek D
Tuberk Toraks; 2013; 61(2):103-9. PubMed ID: 23875587
[TBL] [Abstract][Full Text] [Related]
23. [Contribution of pleural fluid analysis to the diagnosis of pleural effusion].
Ferreiro L; Toubes ME; Valdés L
Med Clin (Barc); 2015 Aug; 145(4):171-7. PubMed ID: 25433793
[TBL] [Abstract][Full Text] [Related]
24. Diagnostically significant variations in pleural fluid pH in loculated parapneumonic effusions.
Maskell NA; Gleeson FV; Darby M; Davies RJ
Chest; 2004 Dec; 126(6):2022-4. PubMed ID: 15596709
[TBL] [Abstract][Full Text] [Related]
25. Clinical utility of pleural fluid NT-pro brain natriuretic peptide (NT-proBNP) in patients with pleural effusions.
Han CH; Choi JE; Chung JH
Intern Med; 2008; 47(19):1669-74. PubMed ID: 18827414
[TBL] [Abstract][Full Text] [Related]
26. Vascular endothelial growth factor in pleural effusions and correlation with radiologic and biochemical parameters.
Bayram N; Karakan Y; Uyar M; Ozyurt B; Filiz A
Niger J Clin Pract; 2018 Jan; 21(1):59-62. PubMed ID: 29411725
[TBL] [Abstract][Full Text] [Related]
27. Parapneumonic effusions and empyema.
Light RW
Clin Chest Med; 1985 Mar; 6(1):55-62. PubMed ID: 3847302
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic Value of Vascular Endothelial Growth Factor, Transforming Growth Factor-β, Interleukin-8, and the Ratio of Lactate Dehydrogenase to Adenosine Deaminase in Pleural Effusion.
Saraya T; Ohkuma K; Watanabe T; Mikura S; Kobayashi F; Aso J; Nunokawa H; Honda K; Ogawa Y; Tamura M; Sada M; Oda M; Inoue M; Yokoyama T; Kurai D; Ishii H; Kimura H; Takizawa H
Lung; 2018 Apr; 196(2):249-254. PubMed ID: 29353318
[TBL] [Abstract][Full Text] [Related]
29. Implications of early sonographic evaluation of parapneumonic effusions in children with pneumonia.
Ramnath RR; Heller RM; Ben-Ami T; Miller MA; Campbell P; Neblett WW; Holcomb GW; Hernanz-Schulman M
Pediatrics; 1998 Jan; 101(1 Pt 1):68-71. PubMed ID: 9417153
[TBL] [Abstract][Full Text] [Related]
30. Proinflammatory cytokines, fibrinolytic system enzymes, and biochemical indices in children with infectious para-pneumonic effusions.
Chiu CY; Wong KS; Huang JL; Tasi MH; Lin TY; Hsieh SY
Pediatr Infect Dis J; 2008 Aug; 27(8):699-703. PubMed ID: 18664985
[TBL] [Abstract][Full Text] [Related]
31. Management of parapneumonic effusions. An analysis of physician practice patterns.
Heffner JE; McDonald J; Barbieri C; Klein J
Arch Surg; 1995 Apr; 130(4):433-8. PubMed ID: 7710346
[TBL] [Abstract][Full Text] [Related]
32. [Elevated pleural copeptin levels can distinguish to exudate from transudates].
Gümüş A; Çınarka H; Karataş M; Kırbaş A; Kayhan S; Şahin Ü
Tuberk Toraks; 2014; 62(4):267-72. PubMed ID: 25581690
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic value of pleural fluid obtained from a chest tube collection system.
Reed RM; Eberlein M; Netzer G; Pickering E; Shanholtz C; Verceles AC; McCurdy MT
Lung; 2015 Feb; 193(1):141-6. PubMed ID: 25394673
[TBL] [Abstract][Full Text] [Related]
34. Increased oxidative stress in exudative pleural effusions: a new marker for the differentiation between exudates and transudates?
Papageorgiou E; Kostikas K; Kiropoulos T; Karetsi E; Mpatavanis G; Gourgoulianis KI
Chest; 2005 Nov; 128(5):3291-7. PubMed ID: 16304274
[TBL] [Abstract][Full Text] [Related]
35. Development and Validation of the COMPLES Score for Differentiating Between Tuberculous Effusions with Low Pleural pH or Glucose and Complicated Parapneumonic Effusions.
Corral-Gudino L; García-Zamalloa A; Prada-González C; Bielsa S; Alexis D; Taboada-Gómez J; Dos-Santos-Gallego PR; Alonso-Fernández MA; Porcel JM
Lung; 2016 Oct; 194(5):847-54. PubMed ID: 27401009
[TBL] [Abstract][Full Text] [Related]
36. Prognostic features of residual pleural thickening in parapneumonic pleural effusions.
Jiménez Castro D; Díaz G; Pérez-Rodríguez E; Light RW
Eur Respir J; 2003 Jun; 21(6):952-5. PubMed ID: 12797487
[TBL] [Abstract][Full Text] [Related]
37. [Parapneumonic pleural effusions and empyema in adults:current practice].
Porcel JM; Light RW
Rev Clin Esp; 2009 Nov; 209(10):485-94. PubMed ID: 19889319
[TBL] [Abstract][Full Text] [Related]
38. Pleural fluid chemical analysis in parapneumonic effusions. A meta-analysis.
Heffner JE; Brown LK; Barbieri C; DeLeo JM
Am J Respir Crit Care Med; 1995 Jun; 151(6):1700-8. PubMed ID: 7767510
[TBL] [Abstract][Full Text] [Related]
39. Safety and Efficacy of Tissue Plasminogen Activator and DNase for Complicated Pleural Effusions Secondary to Abdominal Pathology.
Majid A; Ochoa S; Chatterji S; Fernandez-Bussy S; Kheir F; Rivera E; Cheng G; Folch E
Ann Am Thorac Soc; 2017 Mar; 14(3):342-346. PubMed ID: 28079399
[TBL] [Abstract][Full Text] [Related]
40. Pleural fluid pH in malignant effusions. Diagnostic, prognostic, and therapeutic implications.
Sahn SA; Good JT
Ann Intern Med; 1988 Mar; 108(3):345-9. PubMed ID: 3341671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
